Previous in vitro studies modeling traumatic brain injury, cerebral ischemia/reperfusion injury, and stroke have confirmed the presence of anti-inflammatory effects driven by suppressed activation of the NF-kB and p38MAPK pathways [112,113,114]. The gene discussed is NFKB1; the disease is Cerebral ischemia.